Peptide Database

Comprehensive information on 22 peptides

Dosage:

Showing 22 of 22 peptides

BPC-157

wellnesshealing

Body Protection Compound-157

Promotes angiogenesis, upregulates growth factors (VEGF, EGF), modulates nitric oxide system, anti-inflammatory, stimulates collagen synthesis, influences gut-brain axis

Dose:250-500 mcg once or twice daily
Cycle:4-8 weeks on, 2-4 weeks off
Route:SubQ

TB-500

wellnesshealing

Thymosin Beta-4 Fragment

Sequesters G-actin for cytoskeletal dynamics, promotes cellular migration, stimulates angiogenesis, anti-inflammatory, activates stem cells, cardioprotective

Dose:4mg twice weekly
Cycle:4-6 weeks loading, 4-8 weeks maintenance, 4-6 weeks off
Route:SubQ

Selank

wellnessnootropic

Selank Heptapeptide

Enhances GABAergic transmission, modulates serotonin/dopamine/norepinephrine, increases BDNF, inhibits enkephalin-degrading enzymes, immune modulation

Dose:400 mcg daily
Cycle:2-4 weeks on, 1-2 weeks off
Route:Intranasal

Semax

wellnessnootropic

Semax Heptapeptide (ACTH 4-10 analog)

Significantly increases BDNF/NGF, enhances catecholamine activity, neuroprotection, promotes neuroplasticity, anti-inflammatory, melanocortin receptor activation

Dose:400 mcg daily
Cycle:10-20 days on, 10-20 days off
Route:Intranasal

Thymosin Alpha-1

wellnessimmune

Thymosin Alpha-1 (Tα1)

Enhances T-cell maturation, activates dendritic cells, TLR2/TLR9 signaling, balances Th1/Th2 response, increases NK cell activity, anti-inflammatory

Dose:1.6mg twice weekly
Cycle:4-8 weeks on, 4 weeks off
Route:SubQ

LL-37

wellnessimmune

LL-37 Cathelicidin

Direct antimicrobial action, biofilm disruption, immune cell activation, wound healing promotion, LPS neutralization, chemotaxis

Dose:50-100 mcg daily
Cycle:2-4 weeks acute, 4-8 weeks chronic, equal off-cycle
Route:SubQ

Epithalon

longevitytelomere

Epithalon (Epitalon)

Induces telomerase activity to lengthen telomeres, enhances melatonin production, reduces oxidative DNA damage, modulates aging gene expression, normalizes circadian rhythm

Dose:10mg daily for 10 days
Cycle:10-20 days on, 4-6 months off
Route:SubQ

GHK-Cu

longevityregeneration

GHK-Cu Copper Peptide

Stimulates collagen/elastin synthesis, activates antioxidant enzymes, modulates inflammatory cytokines, resets ~4000 genes toward youthful expression, recruits stem cells, delivers bioavailable copper

Dose:2mg daily
Cycle:4-8 weeks on, 4 weeks off
Route:SubQ

MOTS-c

longevitymitochondrial

MOTS-c (Mitochondrial ORF of 12S rRNA Type-c)

Activates AMPK, improves insulin sensitivity and glucose uptake, enhances fatty acid metabolism, optimizes mitochondrial function, exercise mimetic, enhances stress resistance

Dose:10mg 4x weekly
Cycle:4-8 weeks on, 4 weeks off
Route:SubQ

SS-31

longevitymitochondrial

SS-31 (Elamipretide)

Selectively binds cardiolipin in inner mitochondrial membrane, optimizes electron transport chain, reduces mitochondrial ROS, prevents cardiolipin peroxidation, enhances cytochrome c interaction

Dose:20-30mg daily
Cycle:4-8 weeks on, 4 weeks off
Route:SubQ

Humanin

longevityneuroprotection

Humanin (HN)

Blocks BAX-mediated apoptosis, protects against amyloid-beta toxicity, modulates IGF signaling, promotes STAT3 cell survival, preserves mitochondrial function, improves insulin sensitivity

Dose:2-4mg daily
Cycle:4-8 weeks on, 4 weeks off
Route:SubQ

NMN

longevitynad_precursor

Nicotinamide Mononucleotide

Direct precursor to NAD+ production, activates sirtuins, supports PARP-mediated DNA repair, essential for electron transport chain, regulates circadian genes

Dose:500-750mg daily
Cycle:Continuous daily use
Route:Oral

CJC-1295 (no DAC)

muscle buildingghrh

CJC-1295 without DAC (Mod GRF 1-29)

GHRH receptor agonist, stimulates pituitary GH release, maintains natural GH pulsatility, increases IGF-1, enhances protein synthesis, promotes lipolysis

Dose:100mcg twice daily
Cycle:8-12 weeks on, 4-6 weeks off
Route:SubQ

CJC-1295 (with DAC)

muscle buildingghrh

CJC-1295 with Drug Affinity Complex

Extended half-life GHRH analog, sustained GH elevation, increases IGF-1, enhances protein synthesis, promotes lipolysis

Dose:1-2mg weekly
Cycle:8-12 weeks on, 4-8 weeks off
Route:SubQ

Ipamorelin

muscle buildingghrp

Ipamorelin Pentapeptide

Selective GHS-R1a ghrelin receptor agonist, mimics natural GH pulsatility, minimal cortisol/prolactin effects, elevates IGF-1, may improve gut function

Dose:200mcg twice daily
Cycle:8-12 weeks on, 4-8 weeks off
Route:SubQ

GHRP-2

muscle buildingghrp

Growth Hormone Releasing Peptide-2

Ghrelin receptor agonist, potent GH release, elevates IGF-1, influences gastric motility, modest cortisol/prolactin increase

Dose:150mcg three times daily
Cycle:8-12 weeks on, 4-8 weeks off
Route:SubQ

GHRP-6

muscle buildingghrp

Growth Hormone Releasing Peptide-6

Ghrelin receptor agonist, strong appetite stimulation, GH release, elevates IGF-1, influences gastric motility

Dose:150mcg three times daily
Cycle:8-12 weeks on, 4-8 weeks off
Route:SubQ

Hexarelin

muscle buildingghrp

Hexarelin (Examorelin)

Most potent GHRP for GH stimulation, CD36 receptor binding for cardioprotection, improves heart contractility, more prone to desensitization

Dose:100-200mcg twice daily
Cycle:4-8 weeks on, 4-8 weeks off (shorter due to desensitization)
Route:SubQ

MK-677

muscle buildingghs_oral

MK-677 (Ibutamoren)

Non-peptide oral ghrelin mimetic, sustained 24-hour GH elevation, 55-94% IGF-1 increase, no suppression of natural production, appetite stimulation, sleep improvement

Dose:15-20mg daily
Cycle:8-16 weeks on, 4-8 weeks off
Route:Oral

Tesamorelin

muscle buildingghrh

Tesamorelin (FDA-approved GHRH analog)

FDA-approved 44-amino acid GHRH analog, potent GH release, specifically targets visceral fat, improves lipid profiles, preserves subcutaneous fat

Dose:1.5mg daily
Cycle:12-26 weeks (FDA protocol)
Route:SubQ

Tirzepatide

muscle buildingglp1_gip

Tirzepatide (Mounjaro/Zepbound)

Dual GLP-1/GIP receptor agonist, appetite suppression, glucose-dependent insulin secretion, 15-22% weight loss, potential muscle preservation, cardiovascular benefits

Dose:7.5-10mg weekly
Cycle:Continuous with titration
Route:SubQ

Retatrutide

muscle buildingtriple_agonist

Retatrutide (LY3437943)

Triple GLP-1/GIP/Glucagon receptor agonist, unprecedented weight loss (up to 24.2%), increased energy expenditure, fat oxidation, synergistic metabolic effects

Dose:4-8mg weekly
Cycle:24-48 weeks with titration
Route:SubQ